Journals / Klinik Psikofarmakoloji Bülteni / 2016 / Cilt: 26 - Sayı: 2

The changes of the cognitive and psychomotor functions in the chronic cannabis users after a month of remission

Pages
109–118
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We suggest that future studies to assess cognitive functions after either a shorter (i.e. 1 week) or a longer (i.e. 2 months) period of cannabis abstinence in larger samples may provide further useful data about the relationship between cannabis use and cognitive functions.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In our study, it is aimed to investigate impacts of cannabis use on information processing and psychomotor functions and to examine changes in the cognitive functions at the end of abstinence over a month.
📊
Key Findings & Data:Method: The study was initiated with 34 volunteer participants using cannabis at least over two years, directed by a forensic unit. 34 persons were assessed at admission and were planned to assess after a month of remission.
💡
Conclusion & Impact:We suggest that future studies to assess cognitive functions after either a shorter (i.e. 1 week) or a longer (i.e. 2 months) period of cannabis abstinence in larger samples may provide further useful data about the relationship between cannabis use and cognitive functions.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: In our study, it is aimed to investigate impacts of cannabis use on information processing and psychomotor functions and to examine changes in the cognitive functions at the end of abstinence over a month. Method: The study was initiated with 34 volunteer participants using cannabis at least over two years, directed by a forensic unit. 34 persons were assessed at admission and were planned to assess after a month of remission. As 14 participants discontinued the study 20 participants only were assessed again at the end of a month. The participants were applied The Montreal Cognitive Assessment (MOCA) test, Edinburgh Handedness Inventory, Finger Tapping Test (FTT), Adult Memory and Information Processing Battery (AMIPB) A and B, and simple reaction time tests (auditory and visual) in admission and were applied Finger Tapping Test (FTT), Adult Memory and Information Processing Battery (AMIPB), and simple reaction time tests (auditory and visual) at the end of a month. Results: There was no statistically significant difference between participants continue to the treatment and those discontinue in terms of sociodemographic and clinical characteristics. The participants discontinue were using more daily cannabis dose. The auditory reaction time of the group continue to the treatment decreased statistically significantly after a month whereas there was no statistically significant difference in the visual reaction time. The scores of the AMIPB-A and AMIPB-B were detected statistically higher after a month compared to admission. The score of the dominant hand FTT after a month was detected statistically higher than that in admission whereas there was no statistically significant difference in the non-dominant hand score. Conclusion: Improvements in scores of AMIP-A, AMIP-B, FTT and auditory reaction time after one month of quitting cannabis suggest that cannabis use may impair cognitive functions such as information processing, reaction time and motor functions. We suggest that future studies to assess cognitive functions after either a shorter (i.e. 1 week) or a longer (i.e. 2 months) period of cannabis abstinence in larger samples may provide further useful data about the relationship between cannabis use and cognitive functions.

🔖

Cite This Article

UMUT, G., ATAGUN, M. I., EVREN, C., CENGEL, H. Y., HİSİM, O., KESKİNKİLİC, C., MEMORY, A. (2022). The changes of the cognitive and psychomotor functions in the chronic cannabis users after a month of remission. Klinik Psikofarmakoloji Bülteni, Cilt: 26 - Sayı: 2, 109–118. https://ajindex.com/articles/573883

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. World Health Organization (WHO) Cannabis: A health perspective and research agenda. 1997. http://whqlibdoc. who.int/hq/1997/WHO_msa_PSA_97.4.pdf (28.01.2012)
  2. ONDCP Releases. Marijuana Sourcebook 2008 http:// higheredcenter.ed.gov/thisweek/ondcp-releases-2008- marijuana-sourcebook 3. SAMHSA. Report No.; DHHS Publication No. SMA 06-4194. Rockville, MD: Office of Applied Studies; 2006. Results from the 2005 National Survey on Drug Use and Health: National Findings
  3. Akvardar Y, Tumuklu M, Akdede BB, Ulas H, Kitis A, Alptekin K. Substance use among patients with schizophrenia in a university hospital. Klinik Psikofarmakoloji Bulteni - Bulletin of Clinical Psychopharmacology 2004;14(4):191-7
  4. Nordstrom BR, Levin FR. Treatment of cannabis use disorders: a review of the literature. Am J Addict 2007;16(5):331-42. [CrossRef] 6. Morrison PD, Zois V, McKeown DA, Lee TD, Holt DW, Powell JF, et al. The acute effects of synthetic intravenous Delta9- tetrahydrocannabinol on psychosis, mood and cognitive functioning. Psychol Med 2009;39(10):1607-16. [CrossRef] 7. Gonzalez R. Acute and non-acute effects of cannabis on brain functioning and neuropsychological performance. Neuropsychol Rev 2007;17(3):347-61. [CrossRef] 8. Shrivastava A, Johnston M, Tsuang M. Cannabis use and cognitive dysfunction. Indian J Psychiatry 2011;53(3):187-91. [CrossRef] 9. Pope HG Jr, Yurgelun-Todd D. The residual cognitive effects of heavy marijuana use in college students. JAMA 1996;275(7):521-7. [CrossRef] 10. Fletcher JM, Page JB, Francis DJ, Copeland K, Naus MJ, Davis CM, et al. Cognitive correlates of long-term cannabis use in Costa Rican men. Arch Gen Psychiatry 1996;53(11):1051-7. [CrossRef] 11. Solowij N, Stephens RS, Roffman RA, Babor T, Kadden R, Miller M, et al. Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA 2002;287(9):1123- 31. [CrossRef] 12. Johansson E, Agurell S, Hollister LE, Halldin MM. Prolonged apparent half-life of delta 1-tetrahydrocannabinol in plasma of chronic marijuana users. J Pharm Pharmacol 1988;40(5):374-5. [CrossRef] 13. Haney M, Ward AS, Comer SD, Foltin RW, Fischman MW. Abstinence symptoms following oral THC administration to humans. Psychopharmacology (Berl) 1999;141(4):395-404. [CrossRef] 14. Pope HG Jr, Gruber AJ, Hudson JI, Huestis MA, Yurgelun-Todd D. Neuropsychological performance in long-term cannabis users. Arch Gen Psychiatry 2001;58(10):909-15. [CrossRef] 15. Dragt S, Nieman DH, Becker HE, van de Fliert JR, Din